Type 1 Diabetes (T1D) is a severe autoimmune disorder marked by the immune system's targeted destruction of pancreatic beta cells, leading to a critical ...
Researchers from the National Institutes of Health have discovered a biomarker in the DNA of five different types of cancerous tumors, as well as evidence that the genetic signature may be present in ...
Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in angioimmunoblastic T cell lymphoma (AITL), a type of nodal T cell lymphoma, and ...
An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients. Stay ahead of policy, cost, and value—subscribe ...
In this precision oncology era, where molecular profiling at the individual patient level becomes increasingly accessible and affordable, more and more clinical trials are now driven by biomarkers, ...
A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology. Melanoma, the deadliest ...
Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...
Data are lacking about the relationship between type 2 diabetes and the risks of heart failure (HF) among people with elevated cardiac biomarkers. This information is particularly scant among Black ...
FDA provides supportive feedback on proposed statistical analysis plan for neurofilament biomarker analysis of Clene’s NIH-sponsored Expanded Access Program NfL EAP biomarker analyses to be conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback